-$0.06 EPS Expected for Tyme Technologies Inc (TYME) This Quarter
Equities analysts forecast that Tyme Technologies Inc (NASDAQ:TYME) will post earnings of ($0.06) per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Tyme Technologies’ earnings. Tyme Technologies posted earnings of ($0.04) per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 50%. The company is scheduled to report its next earnings report on Tuesday, February 13th.
On average, analysts expect that Tyme Technologies will report full year earnings of ($0.23) per share for the current year. For the next fiscal year, analysts forecast that the business will post earnings of ($0.39) per share. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Tyme Technologies.
TYME has been the subject of several research reports. HC Wainwright initiated coverage on Tyme Technologies in a report on Friday, December 15th. They set a “buy” rating and a $8.00 price target for the company. Evercore ISI initiated coverage on Tyme Technologies in a report on Friday, November 17th. They set an “outperform” rating and a $7.00 price target for the company. BidaskClub upgraded Tyme Technologies from a “sell” rating to a “hold” rating in a report on Thursday, January 4th. Finally, Canaccord Genuity initiated coverage on Tyme Technologies in a report on Wednesday, January 3rd. They set a “buy” rating for the company.
Shares of Tyme Technologies (NASDAQ TYME) traded down $0.01 during trading on Friday, hitting $3.65. The stock had a trading volume of 62,500 shares, compared to its average volume of 162,636. Tyme Technologies has a fifty-two week low of $2.14 and a fifty-two week high of $9.50.
COPYRIGHT VIOLATION NOTICE: “-$0.06 EPS Expected for Tyme Technologies Inc (TYME) This Quarter” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://theolympiareport.com/2018/02/14/0-06-eps-expected-for-tyme-technologies-inc-tyme-this-quarter.html.
About Tyme Technologies
Tyme Technologies, Inc is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.